Abstract
Background
A subgroup of patients with Major Depressive Disorder shows signs of low-grade inflammation and metabolic abberances, while antidepressants can induce weight gain and subsequent metabolic disorders, and lacking antidepressant response is associated with inflammation.
Objectives
A comprehensive investigation of patient phenotypes and their predictive capability for weight gain and treatment response after psychotropic treatment will be performed. The following factors will be analyzed: inflammatory and metabolic markers, gut microbiome composition, lifestyle indicators (eating behavior, physical activity, chronotype, patient characteristics (childhood adversity among others), and polygenic risk scores.
Methods
Psychiatric inpatients with at least moderate Major Depressive Disorder will be enrolled in a prospective, observational, naturalistic, monocentric study using stratified sampling. Ethical approval was obtained. Primary outcomes at 4 weeks will be percent weight change and symptom score change on the Montgomery Asberg Depression Rating Scale. Both outcomes will also be binarized into clinically relevant outcomes at 5% weight gain and 50% symptom score reduction. Predictors for weight gain and treatment response will be tested using multiple hierachical regression for continuous outcomes, and multiple binary logistic regression for binarized outcomes. Psychotropic premedication, current medication, eating behavior, baseline BMI, age, and sex will be included as covariates. Further, a comprehensive analysis will be carried out using machine learning. Polygenic risk scores will be added in a second step to estimate the additional variance explained by genetic markers. Sample size calculation yielded a total amount of N = 171 subjects.
Discussion
Patient and physician expectancies regarding the primary outcomes and non-random sampling may affect internal validity and external validity, respectively. Through the prospective and naturalistic design, results will gain relevance to clinical practice. Examining the predictive value of patient profiles for weight gain and treatment response during pharmacotherapy will allow for targeted adjustments before and concomitantly to the start of treatment.
Publisher
Public Library of Science (PLoS)
Reference60 articles.
1. Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder;KL Chan;Physiology (Bethesda),2019
2. Inflammatory theory of depression;P Gałecki;Psychiatr Pol.,2018
3. Is depression an inflammatory disorder?;CL Raison;Curr Psychiatry Rep.,2011
4. Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression;C Schiweck;Transl Psychiatry,2020
5. Effects of antidepressant and antipsychotic use on weight gain: A systematic review;L Alonso-Pedrero;Obes Rev.Dec,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review;European Journal of Investigation in Health, Psychology and Education;2023-08-12